Cargando…
Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
This letter to the editor comments on a recently published article on seroconversion rates after COVID-19 vaccination.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632302/ https://www.ncbi.nlm.nih.gov/pubmed/36018054 http://dx.doi.org/10.1093/oncolo/oyac169 |
| Sumario: | This letter to the editor comments on a recently published article on seroconversion rates after COVID-19 vaccination. |
|---|